Endometrial | Maryland Oncology Hematology Endometrial – Maryland Oncology Hematology

Trial ID ESR 22-21698 (EIMPRIS)

NCT05438498
clinicaltrials.gov ID
Phase II/III

Trial ID 21461

NCT05173987
clinicaltrials.gov ID
USOR ID: 21461 Phase III
A Phase 3 Randomized, Open-label, Active-comparator Controlled Clinical Study of Pembrolizumab vs. Platinum Doublet Chemotherapy in Participants With Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma in the First-line Setting

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology